Pneumococcal Vaccine Recommendations 

• Age-based: All patients 65 years or older should receive either PCV20 once or PCV15 followed by PPSV23 at least one year later
• Risk-based: Patients aged 19-64 with a high-risk condition should receive one dose of PCV20 or a combination of PCV15 and PPSV23

 

 

 

 

HPV Vaccine Recommendations

• Ages 18-26: Recommended for everyone that is not adequately vaccinated when younger
• Ages 27-45: Consider discussing vaccination with those that are most likely to benefit based on shared clinical decision-making
  • Vaccination prevents new HPV infections but does not treat existing HPV infections or diseases
  • Most sexually active adults have already been exposed to HPV, although not necessarily all the HPV types targeted by vaccination
  • At any age, having a new sexual partner is a risk factor for acquiring a new HPV infection

Shingles Vaccine Recommendations 

• Immunocompetent: Ages 50 and older
  • Whether or not a prior episode of herpes zoster is reported
  • Whether or not a prior dose of Zostavax is reported
• Immunocompromised: Ages 19 and older

See the table below for more information on coding and dosing schedule for these vaccinations.